Last 167.50 GBp
Change Today 0.00 / 0.00%
Volume 25.9K
EAH On Other Exchanges
Symbol
Exchange
London
Berlin
As of 12:38 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

eco animal health group plc (EAH) Snapshot

Open
167.50 GBp
Previous Close
167.50 GBp
Day High
167.50 GBp
Day Low
167.50 GBp
52 Week High
09/23/13 - 219.00 GBp
52 Week Low
08/13/14 - 161.50 GBp
Market Cap
104.6M
Average Volume 10 Days
26.8K
EPS TTM
0.04 GBp
Shares Outstanding
62.4M
EX-Date
08/6/14
P/E TM
38.6x
Dividend
4.67 GBp
Dividend Yield
2.79%
Current Stock Chart for ECO ANIMAL HEALTH GROUP PLC (EAH)

Related News

No related news articles were found.

eco animal health group plc (EAH) Related Businessweek News

No Related Businessweek News Found

eco animal health group plc (EAH) Details

ECO Animal Health Group plc is engaged in the development, manufacture, supply, and distribution of animal health products worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortet and Oxytet for the treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

165 Employees
Last Reported Date: 07/28/14
Founded in 1972

eco animal health group plc (EAH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

eco animal health group plc (EAH) Key Developments

ECO Animal Health Group plc, Annual General Meeting, Sep 17, 2014

ECO Animal Health Group plc, Annual General Meeting, Sep 17, 2014., at 10:00 GMT Standard Time. Location: 78 Coombe Road. Agenda: To receive the annual report for the year ended on 31 March 2014; to consider the re-election of Director; to re-elect Reeves & Co LLP as auditors and to authorise the Directors to agree the auditors' remuneration; to allow the Board to allot unissued shares up to an aggregate nominal value of GBP 281,288; to authorize the company to make market purchases up to 624,742 of its shares; and to allow the Board to issue equity securities for cash up to a nominal value of GBP 281,288.

Eco Animal Health Group Declares Dividend, Payable on 15 August 2014

Eco Animal Health Group board declared a dividend for the year of 4.2 pence per share, an increase of 5% over the level last year. The dividend will be paid on 15th August to shareholders on the register on 8th August 2014.

ECO Animal Health Group plc Announces Consolidated Earnings Results for the Year Ended March 31, 2014 ; Provides Guidance for the Year 2014

ECO Animal Health Group plc announced consolidated earnings results for the year ended March 31, 2014. For the year, the company reported revenue of £31,864,593, profit from operating activities of £3,968,195, profit before income tax of £3,683,064, profit for the year from continuing operations of £3,081,000 or 4.3 pence per diluted share, profit attributable to owners of the parent company of £2,431,143 or 4.3 pence per diluted share, net cash from operating activities of £6,203,587, acquisition of property, plant and equipment of £31,517 compared to the revenue of £28,985,954, profit from operating activities of £3,529,795, profit before income tax of £3,316,090, profit for the year from continuing operations of £3,123,603 or 5.03 pence per diluted share, profit attributable to owners of the parent company of £2,616,892 or 4.9 pence per diluted share, net cash from operating activities of £4,333,205, acquisition of property, plant and equipment of £38,642 for the previous year. On company basis, net cash absorbed by operating activities was £3,787,038 compared to the £2,045,098 for the previous year. Acquisition of property, plant and equipment was £790 compared to the £394 for the previous year. The current year has started well with major markets maintaining their rate of growth with particularly good demand from customers in the US and Canada. The strength of sterling may remain an issue, but it will not divert from objective of developing global business. Aivlosin sales are growing rapidly, boosted particularly by North American demand where business is still in its early stages but showing very significant and exciting potential. The company looks forward with optimism and is confident of delivering another strong performance in the current year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EAH:LN 167.50 GBp 0.00

EAH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EAH.
View Industry Companies
 

Industry Analysis

EAH

Industry Average

Valuation EAH Industry Range
Price/Earnings 38.1x
Price/Sales 3.0x
Price/Book 1.4x
Price/Cash Flow 20.7x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECO ANIMAL HEALTH GROUP PLC, please visit www.ecoanimalhealthgroupplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.